Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 04:54 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Warfarine in Unexplained Oligohydramnios
NCT01569035 · Woman's Health University Hospital, Egypt · PHASE4 · terminated · last registry update 2021-01-07 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
No reason was published
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | The registry record gives no reason | – | Registry record, Woman's Health University Hospital, Egypt |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against VKORC1 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2021-11-30Results posted on the registry: University of South Florida, Apixaban + Warfarin (NCT02283294)
- 2021-11-24Results posted on the registry: AtriCure, Inc., Anticoagulation Therapy (NCT02701062)
- 2021-08-25Also stopped (withdrawn): First Affiliated Hospital Xi'an Jiaotong University, Warfarin Sodium (NCT04482842)
- 2021-08-19Also stopped (terminated): Rajaie Cardiovascular Medical and Research Center, Rivaroxaban + Warfarin (NCT03926156)
- 2021-07-22Results posted on the registry: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, rivaroxaban + Warfarin (NCT02376010)
- 2021-07-08Results posted on the registry: Universiti Sains Malaysia, Apixaban 5 MG Oral Tablet [ELIQUIS] + Warfarin Sodium (NCT02982590)
- 2021-03-25Also stopped (withdrawn): University of Texas Southwestern Medical Center, Warfarin (NCT03536208)
- 2021-03-16Results posted on the registry: Mayo Clinic, Apixaban + Warfarin (NCT03839355)
- 2021-03-16Also stopped (terminated): Mayo Clinic, Apixaban + Warfarin (NCT03839355)
- 2021-03-02Results posted on the registry: Qilu Hospital of Shandong University, Nadroparin calcium, warfarin (NCT04173429)
- 2021-01-29Phase 3 first posted: Kyushu University, Edoxaban + Warfarin Potassium (NCT04730037)
- 2021-01-27Phase 3 first posted: University of Birmingham, Warfarin + direct oral anticoagulants (NCT04727437)
- 2021-01-22Results posted on the registry: Sanford Health, Apixaban + Warfarin (NCT02889562)
- 2020-12-29Results posted on the registry: Christopher Granger, MD, apixaban + warfarin (NCT02942407)
- 2020-12-01Results posted on the registry: Imperial College London, Warfarin (NCT00180674)
- 2020-10-29Results posted on the registry: Abbott Medical Devices, Warfarin + acetylsalicylic acid (ASA) therapy (NCT02836652)
- 2020-10-19Results posted on the registry: Ohio State University, Atorvastatin + Anticoagulation Therapy (NCT02331095)
- 2020-10-19Also stopped (terminated): Ohio State University, Atorvastatin + Anticoagulation Therapy (NCT02331095)
- 2020-09-29Phase 3 first posted: Damascus University, Rivaroxaban + Warfarin (NCT04569279)
- 2020-08-12Results posted on the registry: Mayo Clinic, Vascular Boot + Standard of Care (NCT03465735)
- 2020-08-12Also stopped (terminated): Mayo Clinic, Vascular Boot + Standard of Care (NCT03465735)
- 2020-07-01Results posted on the registry: Eli Lilly and Company, warfarin + enzastaurin (NCT01388335)
- 2020-06-30Also stopped (terminated): Electrophysiology Research Foundation, Edoxaban + Warfarin (NCT02561897)
- 2020-05-15Also stopped (terminated): Hospital Geral Roberto Santos, Rivaroxaban 15 mg + Warfarin (NCT03566303)
- 2020-04-14Results posted on the registry: Abbott Medical Devices, a drug against VKORC1 (NCT01118299)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision